ResearcherAsan Medical CenterNo recent work listed

Seungwoo Hong

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-7953-8433; OpenAlex author ID A5033430968. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 2

Papers, trials and grants by year

2020: 1 paper

Papers 1

Chemosensitivity to HM90822, a novel synthetic IAP antagonist, is determined by p-AKT-inducible XIAP phosphorylation in human pancreatic cancer cells. Co-author DOI 10.1007/s10637-020-00956-9 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Jai-Hee Moon · 1 shared paper, 2020 · strength 0.08
- Paper Chemosensitivity to HM90822, a novel synthetic IAP antagonist, is determined by p-AKT-inducible XIAP phosphorylation in… DOI 10.1007/s10637-020-00956-9 ↗
Tae Won Kim · 1 shared paper, 2020 · strength 0.08
- Paper Chemosensitivity to HM90822, a novel synthetic IAP antagonist, is determined by p-AKT-inducible XIAP phosphorylation in… DOI 10.1007/s10637-020-00956-9 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.